about
Chronic HCV infection: epidemiological and clinical relevanceHepatitis C virus: A time for decisions. Who should be treated and when?Occult HCV Infection: The Current State of KnowledgeEpidemiology of hepatitis C virus in IranA New Twist to a Chronic HCV Infection: Occult Hepatitis CManagement of hepatitis C virus infection in hemodialysis patients.Occult hepatitis C virus infection in Iranian hemodialysis patients.Occult Hepatitis C Virus Infection in Hemodialysis Patients; Single Center StudyOccult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosisViral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.Seronegative hepatitis C virus infection.Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection.Virus-Specific Cellular Response in Hepatitis C Virus Infection.Occult hepatitis C virus infection among Egyptian hemodialysis patients.Comparison of neutralization profiles for anti-HCV reactive donor samples with or without detectable HCV RNA.Detection of occult hepatitis C virus among healthy spouses of patients with HCV infection.Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection.Anti-HCV immunoblot indeterminate results in blood donors: non-specific reactivity or past exposure to HCV?Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.Seronegative and occult hepatitis C virus infections in patients with hematological disorders.Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.Lymphomagenesis-related gene expression in B cells from sustained virological responders with occult hepatitis C virus infection.Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies.Expression, Purification and Immunogenic Description of a Hepatitis C Virus Recombinant CoreE1E2 Protein Expressed by Yeast Pichia pastoris.Occult hepatitis C virus infection in patients with autoimmune hepatitis.Treatment of occult hepatitis C virus infection: does it need special attention?Natural history of vertically acquired HCV infection and associated autoimmune phenomena.Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.Screening blood donors for hepatitis C virus: the challenge to consider cost-effectiveness.Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study.Screening for occult hepatitis C virus infection: Does it need special attention?Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection.
P2860
Q21261812-F12D3339-974F-483D-A749-700C0018AE6FQ26768274-56BC02B1-9725-46C7-A5B9-6320CD1A1414Q26770595-EEE707EB-8075-479A-AF27-C58E5747A495Q26781996-782DE8D9-5D33-48F4-9E8B-CCC3E2D346ABQ26798189-B5029BDC-3B92-4EE2-8F8E-E32BE38466F5Q33845152-F5F4D019-B671-4A74-9DA7-43FB726CF07CQ36130807-BF1C27D3-C9F0-42AC-9700-E8177840C98EQ36497984-8F7EDD71-AECF-4BF7-A065-EA222225BE29Q37204495-CA01B3AF-DCB3-4EB8-830E-87C52E87079FQ37281965-2269581D-B2F4-4358-ABDA-5B9396EFD3B4Q37631608-84B54D1B-402D-4094-821F-AB3800A69A4CQ38105969-95252999-6D2B-4A3D-AF69-AC760BBB1E95Q38597605-1AD0A7EA-3E62-4949-AB42-076EB0BB5BE7Q38855890-1F0B4A62-FEE3-4492-8A77-5E5AADAAB2C5Q38861617-42195141-BBE0-4A52-A022-1890B0779B12Q38985757-ABC5B996-0CB3-4E0C-9C3D-3452A6E2B3A8Q39275991-558A3C77-FECF-485D-A7C0-E26E74153213Q40076257-1D1AD2A7-7D4E-4095-893B-077AD977BFFFQ40329699-C8DBEDBB-069B-4568-ACE3-B4511C6D9FF3Q40528384-29F64EE2-FA8A-4BDF-8D9B-ECB9944F55B2Q40692627-98621F8E-5F59-4928-AF04-0A2B26CB6072Q40766567-529E1E40-FB78-4177-BD3E-11CB6D79FCA1Q40809063-C8780D5F-5854-49C4-A3A9-CD3915ECFD6EQ41190392-264BE5C7-A231-4F2C-B73A-27CB6FD023A4Q41692201-E623895B-9D02-413C-B5DF-2C7C4F96743AQ41827610-4EF8BA45-1FFA-4A4E-A07C-53FBA0207ECBQ42226319-C9918D31-719C-4240-992D-0D48E398BBE6Q42262339-ED31E226-B92E-4A4F-AE36-5B6377E45B90Q44878545-B9E98072-98C2-468E-9324-2465A77BF4E8Q45323682-815D4507-72D0-4813-8EEA-8B38B9F09E02Q45343938-25A9D108-1627-4E4C-AA5C-E0E350173BB0Q47274792-074A2C63-F674-4B24-9B93-A7E096849AC3Q55259485-BA890856-B355-48A9-BE99-3DD5191EA11F
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
New perspectives in occult hepatitis C virus infection
@ast
New perspectives in occult hepatitis C virus infection
@en
New perspectives in occult hepatitis C virus infection
@en-gb
New perspectives in occult hepatitis C virus infection
@nl
type
label
New perspectives in occult hepatitis C virus infection
@ast
New perspectives in occult hepatitis C virus infection
@en
New perspectives in occult hepatitis C virus infection
@en-gb
New perspectives in occult hepatitis C virus infection
@nl
prefLabel
New perspectives in occult hepatitis C virus infection
@ast
New perspectives in occult hepatitis C virus infection
@en
New perspectives in occult hepatitis C virus infection
@en-gb
New perspectives in occult hepatitis C virus infection
@nl
P2093
P2860
P356
P1476
New perspectives in occult hepatitis C virus infection
@en
P2093
Inmaculada Castillo
Javier Bartolomé
Juan Antonio Quiroga
Vicente Carreño
P2860
P304
P356
10.3748/WJG.V18.I23.2887
P407
P577
2012-06-21T00:00:00Z